ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations

Li, Kai; Cao, Li; Li, Cheukfai; Wu, Jundong; Chen, Bo; Zhang, Guochun; Li, Xueri; Wen, Lingzhu; Jia, Minghan; Wei, Guangnan; Lin, Jiali; Li, Yingzi; Zhang, Yuchen; Mok, Hsiaopei; Ren, Chongyang; Wang, Yulei; Qi, Xiaofang; Guo, Lijie; Che, Yue; Liao, Ning*广东省人民医院; 南方医科大学; 汕头大学
Cancer Medicine2023-3DOI: 10.1002/cam4.5314
7阅读
引用收藏
分享

摘要

BackgroudThere were limitations existing in programmed cell-death ligand 1 (PD-L1) as predictive biomarkers for breast cancer (BC), hence exploring the correlation between PD-L1 levels and other biomarkers in BC may become a very useful therapeutic clinical tool. @@@ MethodsA total of 301 Chinese patients with different BC subtypes including 47 HR+/HER2+, 185 HR+/HER2-, 38 HR-/HER2+, and 31 triple-negative breast cancer (TNBC) were enrolled in our study. Next-generation sequencing based Yuansu450 gene panel was used for genomic alteration identification and PD-L1 expression was tested using immunohistochemistry. @@@ ResultsThe most prevalent BC-related mutations were TP53 mutations, followed by mutations in PIK3CA, ERBB2, CDK12, and GATA3 in our Chinese cohort. We found that mutations DDR2 and MYCL were only mutated in HR-/HER2+ subtype, whereas H3-3A and NRAS mutations were only occurred in HR-/HER2- subtype. The percentage of patients with PD-L1-positive expression was higher in patients with HR-/HER2- mainly due to the percentage of PD-L1-high level. Mutational frequencies of TP53, MYC, FAT4, PBRM1, PREX2 were observed to have significant differences among patients with different BC subtypes based on PD-L1 levels. Moreover, a positive correlation was observed between TMB and PD-L1 level in HR+/HER2- subtype, and showed that the proportion of patients with high PD-L1 expression was higher than that of patients with low PD-L1 expression in the HR+/HER2- and HR+/HER2+ cohorts with high Ki67 expression. @@@ ConclusionsThe genomic alterations based on PD-L1 and other biomarkers of different cohorts may provide more possibilities for the treatment of BC with different subtypes.

学科与关键词

关键词
breast cancerKi67next-generation sequencingPD-L1TMB
相关
加载中…
  • Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer
    Li, Yue; Li, Chong; Jiang, Ya; Han, Xue; Liu, Sisi; Xu, Xiuxiu; Tang, Wanxiangfu; Ou, Qiuxiang; Bao, Hua; Wu, Xue; Shao, Yang; Xing, Minyan; Zhang, Yixiang*; Wang, Yuezhen*Journal of Oncology, 2022, 2022: 1763778.被引 1
  • Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
    Li, Kang; Liu, Jun; Wu, Lin; Xiao, Yajie; Li, Jia; Du, Haijian; Zhao, Zhikun; Sun, Chao; Zhao, Yongtian; Yang, Jie; Wu, Dongfang; Zhao, Zhuxiang*; Chen, Bolin*Cancer Cell International, 2022, 22(1): 138.被引 7
  • Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status
    Zhang, Guochun; Ren, Chongyang; Li, Cheukfai; Wang, Yulei; Chen, Bo; Wen, Lingzhu; Jia, Minghan; Li, Kai; Mok, Hsiaopei; Cao, Li; Chen, Xiaoqing; Lin, Jiali; Wei, Guangnan; Li, Yingzhi; Zhang, Yuchen; Balch, Charles M.; Liao, Ning*BMC Medicine, 2022, 20(1): 142.被引 47
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Medicine
发表日期
2023-03
卷期
第 12 卷, 第 5 期
页码
5195-5208
DOI
10.1002/cam4.5314
语言
ENGLISH
成果收录
SCIE

作者

  • L

    Li, Kai (第一作者)

    guangdong prov peoples hosp

  • C

    Cao, Li

    guangdong prov peoples hosp

查看全部 20 位作者收起作者
  • L

    Li, Cheukfai

    guangdong prov peoples hosp

  • W

    Wu, Jundong

    shantou univ

  • C

    Chen, Bo

    guangdong prov peoples hosp

  • Z

    Zhang, Guochun

    guangdong prov peoples hosp

  • L

    Li, Xueri

    guangdong prov peoples hosp

  • W

    Wen, Lingzhu

    guangdong prov peoples hosp

  • J

    Jia, Minghan

    guangdong prov peoples hosp

  • W

    Wei, Guangnan

    guangdong prov peoples hosp

  • L

    Lin, Jiali

    guangdong prov peoples hosp · 2 · southern med univ

  • L

    Li, Yingzi

    guangdong prov peoples hosp

  • Z

    Zhang, Yuchen

    guangdong prov peoples hosp

  • M

    Mok, Hsiaopei

    guangdong prov peoples hosp

  • R

    Ren, Chongyang

    guangdong prov peoples hosp

  • W

    Wang, Yulei

    guangdong prov peoples hosp

  • Q

    Qi, Xiaofang

  • G

    Guo, Lijie

  • C

    Che, Yue

  • L

    Liao, Ning (通讯)

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417